In vitro cytochrome P450-mediated hepatic activities for five substrates in specific pathogen free chickens

Area of Science:

• Pharmacology
• Comparative Toxicology
• Biochemistry

Background:

• Cytochrome P450 (CYP) enzymes are crucial for drug metabolism.
• Understanding interspecies differences in CYP activity is vital for drug development and risk assessment.
• Japanese leghorn chickens and beagle dogs represent distinct mammalian and avian models.

Purpose of the Study:

• To quantify and compare total hepatic CYP content and activity across five key substrates in chickens and dogs.
• To evaluate the drug-metabolizing capacity of chicken liver microsomes.
• To provide insights into species-specific drug pharmacokinetics.

Main Methods:

• Measurement of total hepatic microsomal CYP content.
• In vitro assessment of CYP-mediated activities using five specific substrates: bufuralol 1-hydroxylation, ethoxyresorufin O-deethylation, S-mephenytoin 4-hydroxylation, testosterone 6beta-hydroxylation, and tolbutamide hydroxylation.
• Calculation and comparison of kinetic parameters (Vmax, Km, intrinsic clearance) between species.

Main Results:

• Total CYP content in chickens was comparable to humans and some non-mammalian vertebrates but lower than in dogs.
• Intrinsic clearance for bufuralol 1-hydroxylation, ethoxyresorufin O-deethylation, S-mephenytoin 4-hydroxylation, and testosterone 6beta-hydroxylation was lower in chickens than in dogs.
• Tolbutamide hydroxylation activity was significantly higher in chickens compared to dogs.

Conclusions:

• Chicken liver exhibits distinct CYP-mediated drug metabolism profiles compared to dogs.
• While overall CYP activity is lower in chickens, specific pathways like tolbutamide hydroxylation are more pronounced.
• These species-specific differences are important considerations for preclinical drug testing and xenobiotic metabolism studies.